Home / Participate in Research /
Research Study for Children Ages 2.5-7 Years with Concern for Autism or Who are Typically Developing
This study will examine if a new investigational medical device, called the EarliPointTM Evaluation for Autism Spectrum Disorder, can be used to diagnose autism in children ages 31-84 months. The device detects the presence and severity of autism spectrum disorder and related developmental delays.
Study information
The EarliPointTM Evaluation for Autism Spectrum Disorder (the device) tracks where children are looking as they watch videos on a screen, which shows us how typically developing children and children with autism visually explore the world differently. This study is looking at whether the device can give a comparable results to current diagnostic tests performed by clinicians.
What will my family be asked to do?
To participate in the study, you will be asked to review an Informed Consent document which explains all the details of the study. If you agree to allow your child to participate, you will be asked to sign and return the consent document to the researchers. You and your child will be asked to attend one study visit. Your child will undergo testing by the EarliPoint device, and the researchers will observe and evaluate your child’s developmental status and conduct an expert clinician diagnosis for autism spectrum disorder and related developmental delays.
Your child may be eligible if they:
- Are 31-84 months of age
- Are suspected of having ASD or are typically developing
- Are physically able to sit in a chair, highchair, or booster seat at a table and watch age- appropriate videos on a screen
- Have normal to corrected-to-normal vision and hearing
- Are able to understand instructions presented in English
How long will this take?
Your child will participate in one study visit. They will watch some social videos on the device and undergo assessments. This study uses gold-standard diagnostic assessments that can be lengthy. The entire visit can take around 4 hours.
I would like to learn more. What do I do next?
Contact the study coordinator, Stacy Riffle, for more information at:
Email: stacy.riffle@seattlechildrens.org
Phone: 206-987-7502
Principal Investigator: Mendy Minjarez, PhD
More Info: Seattle Children’s, PDF
Research Study for Children Ages 2.5-7 Years with Concern for Autism or Who are Typically Developing
This study will examine if a new investigational medical device, called the EarliPointTM Evaluation for Autism Spectrum Disorder, can be used to diagnose autism in children ages 31-84 months. The device detects the presence and severity of autism spectrum disorder and related developmental delays.
Study information
The EarliPointTM Evaluation for Autism Spectrum Disorder (the device) tracks where children are looking as they watch videos on a screen, which shows us how typically developing children and children with autism visually explore the world differently. This study is looking at whether the device can give a comparable results to current diagnostic tests performed by clinicians.
What will my family be asked to do?
To participate in the study, you will be asked to review an Informed Consent document which explains all the details of the study. If you agree to allow your child to participate, you will be asked to sign and return the consent document to the researchers. You and your child will be asked to attend one study visit. Your child will undergo testing by the EarliPoint device, and the researchers will observe and evaluate your child’s developmental status and conduct an expert clinician diagnosis for autism spectrum disorder and related developmental delays.
Your child may be eligible if they:
- Are 31-84 months of age
- Are suspected of having ASD or are typically developing
- Are physically able to sit in a chair, highchair, or booster seat at a table and watch age- appropriate videos on a screen
- Have normal to corrected-to-normal vision and hearing
- Are able to understand instructions presented in English
How long will this take?
Your child will participate in one study visit. They will watch some social videos on the device and undergo assessments. This study uses gold-standard diagnostic assessments that can be lengthy. The entire visit can take around 4 hours.
I would like to learn more. What do I do next?
Contact the study coordinator, Stacy Riffle, for more information at:
Email: stacy.riffle@seattlechildrens.org
Phone: 206-987-7502
Principal Investigator: Mendy Minjarez, PhD
More Info: Seattle Children’s, PDF
